Brian Underwood shares that the Men's Health fall issue starring Drake Maye is on newsstands, with peptides among the topics inside.
Recap by typeshit. Post by @thebrianunderwood on Instagram.
An investing platform's company history runs from Lilly's 1876 founding through Humulin and Prozac to its obesity drug boom. Background, not news.
Generic advice that a lack of hunger doesn't mean you've eaten enough, with a nudge toward smaller portions built around protein.
Dr. Mimi Tan points to a wider set of obesity treatments and notes Ozempic is the semaglutide brand meant for type 2 diabetes.
CX11, a daily oral pill, showed up to 11.5% weight loss at 36 weeks in phase 2. The money is meant to carry it through global phase 3.
Weill Cornell's Dhruv Khullar says vials he had lab tested showed lead, endotoxins, and one held half the advertised dose. Experts warn against 'vibes-based' trust.
Dr. Jen Caudle flags gaps in what social media says about retatrutide, the Lilly drug still in trials, and asks viewers to comment for more.
Loading…